Pharmacy Patient Satisfaction Highlights SPT Week in Review

Top articles of the week from Specialty Pharmacy Times.

3. Pembrolizumab Approved for Any Solid Tumor Containing a Common Biomarker

Indication for the treatment of adults and pediatric patients with solid tumors containing MSI-H or dMMR.

https://www.specialtypharmacytimes.com/news/pembrolizumab-approved-for-any-solid-tumor-containing-a-common-biomarker

2. Sarilumab Receives FDA Approval for Rheumatoid Arthritis

Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.

https://www.specialtypharmacytimes.com/news/sarilumab-receives-fda-approval-for-rheumatoid-arthritis

1. Impact of Patient Satisfaction on Specialty Pharmacy

Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.

https://www.specialtypharmacytimes.com/news/impact-of-patient-satisfaction-on-specialty-pharmacy